» Articles » PMID: 10783433

Delirium in the Terminally Ill

Overview
Specialty Geriatrics
Date 2000 Apr 28
PMID 10783433
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Delirium is highly prevalent in terminally ill patients, especially in the last weeks of life, when some cognitive impairment develops in as many as 85% of patients. Delirium is associated with increased morbidity in terminally ill patients and can interfere with pain and symptom control. The cause of delirium is usually multifactorial and often cannot be found or reversed in dying patients. Nonpharmacologic and pharmacologic interventions are effective in controlling the symptoms of delirium in terminally ill patients. Haloperidol and other newer neuroleptics are safe and effective in eliminating delirium for some patients. In approximately one third of patients, delirium can be managed successfully only by providing sedation.

Citing Articles

Assessing the relationship between the distress levels in patients with irreversible terminal delirium and the good quality of death from the perspective of bereaved family.

Zhou P, Tang C, Wang J, Zhang C, Zhong J BMC Palliat Care. 2025; 24(1):14.

PMID: 39810129 PMC: 11734416. DOI: 10.1186/s12904-025-01652-2.


A Review of Clinical Signs and Symptoms of Imminent End-of-Life in Individuals With Advanced Illness.

Ijaopo E, Zaw K, Ijaopo R, Khawand-Azoulai M Gerontol Geriatr Med. 2023; 9:23337214231183243.

PMID: 37426771 PMC: 10327414. DOI: 10.1177/23337214231183243.


Prevalence of Delirium in End-of-Life Palliative Care Patients: An Observational Study.

Recchia A, Rizzi B, Favero A, Nobili A, Pasina L Med Princ Pract. 2022; 31(2):118-124.

PMID: 35038708 PMC: 9209975. DOI: 10.1159/000521994.


Factors for Timely Identification of Possible Occurrence of Delirium in Palliative Care: A Prospective Observational Study.

Corli O, Santucci C, Uggeri S, Bosetti C, Cattaneo M, Ermolli D Adv Ther. 2021; 38(8):4289-4303.

PMID: 34228345 PMC: 8342371. DOI: 10.1007/s12325-021-01814-7.


Drug therapy for delirium in terminally ill adults.

Finucane A, Jones L, Leurent B, Sampson E, Stone P, Tookman A Cochrane Database Syst Rev. 2020; 1:CD004770.

PMID: 31960954 PMC: 6984445. DOI: 10.1002/14651858.CD004770.pub3.